Wedmont Private Capital’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$600K Buy
1,978
+548
+38% +$152K 0.02% 494
2026
Q1
$398K Buy
1,430
+26
+2% +$7.43K 0.01% 577
2025
Q4
$417K Buy
1,404
+1
+0.1% +$279 0.01% 538
2025
Q3
$377K Sell
1,403
-21
-1% -$5.27K 0.01% 551
2025
Q2
$356K Sell
1,424
-463
-25% -$114K 0.02% 521
2025
Q1
$468K Buy
1,887
+52
+3% +$13.9K 0.02% 401
2024
Q4
$472K Buy
1,835
+205
+13% +$55.2K 0.02% 395
2024
Q3
$450K Buy
1,630
+193
+13% +$53.6K 0.03% 386
2024
Q2
$391K Buy
1,437
+211
+17% +$55.3K 0.02% 411
2024
Q1
$322K Buy
1,226
+18
+1% +$4.73K 0.02% 437
2023
Q4
$311K Buy
1,208
+54
+5% +$12.8K 0.03% 423
2023
Q3
$274K Sell
1,154
-156
-12% -$38K 0.03% 407
2023
Q2
$319K Buy
1,310
+267
+26% +$65K 0.03% 362
2023
Q1
$255K Sell
1,043
-46
-4% -$11.1K 0.03% 382
2022
Q4
$270K Buy
1,089
+191
+21% +$46.3K 0.04% 359
2022
Q3
$201K Buy
+898
New +$214K 0.04% 357

Other funds holding VHT

Wedmont Private Capital's VHT Position: Q2 2026 in Review

Wedmont Private Capital increased its Vanguard Health Care ETF (VHT) stake by 38% in Q2 2026, buying an estimated $152K and bringing the position to 1,978 shares worth $600K. The position accounts for 0.02% of the portfolio, ranked #494.

Wedmont Private Capital first reported a position in VHT in Q3 2022 and has held it in 16 quarters since. 245 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Wedmont Private Capital held 1,978 shares of Vanguard Health Care ETF worth $600K as of Q2 2026.
  • Wedmont Private Capital bought 548 Vanguard Health Care ETF shares in Q2 2026, an estimated $152K.
  • Vanguard Health Care ETF made up 0.02% of Wedmont Private Capital's portfolio in Q2 2026, its #494 holding.
  • Wedmont Private Capital first reported a position in Vanguard Health Care ETF in Q3 2022 and has held it in 16 quarters since.
  • 245 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.